New precision medicine trial shows promise for treating rare brain tumors

Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients.

Related Keywords

Priscilla Brastianos ,Lily Ramsey ,Drug Administration ,Cancer Center ,Central Nervous System Metastasis Center ,Women Hospital Department Of Pathology ,Mass General Cancer Center ,Mass General Brigham ,New England Journal ,Mass General Cancer ,Sandro Santagata ,National Cancer Institute Funded Alliance ,Clinical Trials ,Oncology Network ,Brain ,Brain Tumor ,Humor ,Dancer ,Central Nervous System ,Clinical Trial ,Drugs ,Gene ,Genes ,Enetic ,Healthcare ,Laboratory ,Medicine ,Mek Inhibitor ,Melanoma ,Metastasis ,Utation ,Nervous System ,Neuro Oncology ,Neurosurgery ,Ncology ,Pathology ,Precision Medicine ,Research ,Surgery ,